Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what support his Department has provided to NHS trusts to help ensure that non-invasive cancer treatments take place before patients’ conditions worsen.

The National Health Service continues to increase investment in minimally invasive cancer therapies and radiotherapy and chemotherapy services. Since April 2022, the responsibility for investing in new radiotherapy machines has sat with local systems. This is supported by the 2021 Spending Review, which set aside £12 billion in operational capital for the NHS from 2022 to 2025.

In the 2023/24 Operational Planning Guidance, NHS England announced that it is providing over £390 million in cancer service development funding to Cancer Alliances in each of the next two years to support delivery of the strategy and the operational priorities for cancer, which includes increasing and prioritising diagnostic and treatment capacity for cancer.